1-3 of 3
Thierry Facon
Close
Sort by
Journal Articles

Effective anti-BCMA retreatment in multiple myeloma

Clinical Trials & Observations
Nicolas Gazeau, David Beauvais, Ibrahim Yakoub-Agha, Suman Mitra, Timothy B. Campbell, Thierry Facon, Salomon Manier
Journal: Blood Advances
Blood Adv (2021) 5 (15): 3016–3020.
https://doi.org/10.1182/bloodadvances.2021004176
Published: 2021
Journal Articles

Can palliative care consultation increase integration of palliative care for patients with hematologic malignancies?

Clinical Trials & Observations
Chloé Prod’homme, Licia Touzet, Magali Pierrat, Luc Chevalier, Helene Lesaffre, Celine Berthon, Valerie Coiteux, Sarah Barbieux, David Beauvais, Loïc Bauschert, Marie De Charette, Laure Goursaud, Salomon Manier, Thierry Facon
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2123–2127.
https://doi.org/10.1182/bloodadvances.2021004369
Published: 2021
Journal Articles

Efficacy and safety of carfilzomib-based regimens in frail patients with relapsed and/or refractory multiple myeloma

Clinical Trials & Observations
Thierry Facon, Ruben Niesvizky, Maria-Victoria Mateos, David Siegel, Cara Rosenbaum, Sara Bringhen, Katja Weisel, P. Joy Ho, Heinz Ludwig, Shaji Kumar, Kenneth Wang, Mihaela Obreja, Zhao Yang, Zandra Klippel, Khalid Mezzi, Amanda Goldrick, Christina Tekle, Meletios A. Dimopoulos
Journal: Blood Advances
Blood Adv (2020) 4 (21): 5449–5459.
https://doi.org/10.1182/bloodadvances.2020001965
Published: 2020
Includes: Supplemental data